Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Characteristics Affecting Durability and Tolerability of Imatinib in Patients Switched from Brand to Generic and Newly Diagnosed Patients Initially Prescribed Generic Imatinib for Chronic Myeloid Leukemia

Ariel Denson, PharmD, Kristyn Y. DiSogra, PharmD, BCOP, Justin Arnall, PharmD, BCOP, Srinivasa R. Sanikommu, MD, Nilay A. Shah, MD, Brittany K. Ragon, MD, Thomas G. Knight, MD, Jing Ai, MDPhD, Michael R. Grunwald, MD, Belinda R Avalos, MD, Edward A Copelan, Aleksander L. Chojecki, MD

Blood (2020) 136 (Supplement 1): 14–17.

https://doi.org/10.1182/blood-2020-137250

Published: 2020

Journal Articles

Impact of Letermovir Prophylaxis on Voriconazole Exposure in Allogeneic Hematopoietic Cell Transplant Recipients

Issam S. Hamadeh, PharmD, Michael R. Grunwald, MD, Allison Martin, PharmD, Jai N. Patel, PharmD, Alexandra Shillingburg, PharmD, Ekaterina Kachur, PharmD, Allene COOK, PharmD, Allison Karabinos, PharmD, Jing Ai, MDPhD, Thomas G. Knight, MD, Brittany K. Ragon, MD, Aleksander L. Chojecki, MD, Nilay A. Shah, MD, Srinivasa R. Sanikommu, MD, Belinda R Avalos, MD, Edward A Copelan, Zainab Shahid, MD

Blood (2020) 136 (Supplement 1): 5–6.

https://doi.org/10.1182/blood-2020-141124

Published: 2020

Journal Articles

Complex CSF3R Protein Isoform Interactions Dictate Cytokine Responsiveness

Sara L. Seegers, M.S., Amanda Lance, MS, Lawrence J Druhan, PhD, Belinda R Avalos, MD

Blood (2020) 136 (Supplement 1): 35.

https://doi.org/10.1182/blood-2020-143107

Published: 2020

Journal Articles

Specialty Pharmacy and Physician Partnership Optimizes Clinical Pathway Adherence in Myelofibrosis (MF): Initial Analysis of a Quality Improvement Initiative

Aleksander L. Chojecki, MD, Kristyn Y. DiSogra, PharmD, BCOP, Justin Arnall, PharmD, BCOP, Nicole Cowgill, PharmD, CSP, Srinivasa Reddy Sanikommu, MD, Nilay A. Shah, MD, Charles H. Packman, MD, Brittany K. Ragon, MD, Thomas G. Knight, MD, Jing Ai, MDPhD, Belinda R Avalos, MD, Edward A Copelan, Michael R. Grunwald, MD

Blood (2020) 136 (Supplement 1): 40–41.

https://doi.org/10.1182/blood-2020-136319

Published: 2020

Journal Articles

Minorities Do Not Have Worse Outcomes for Diffuse Large B Cell Lymphoma (DLBCL) If Optimally Managed

Bei Hu, MD, Tommy Chen, Danielle Boselli, MS, Rupali Bose, MS, MBA, James T. Symanowski, PhD, Derek Raghavan, MDPhDFACP,FRACP, Amy Soni, MD, Steven I Park, MD, Belinda R Avalos, MD, Edward A Copelan, Ryan Jacobs, MD, Nilanjan Ghosh, MD PhD

Blood (2019) 134 (Supplement_1): 425.

https://doi.org/10.1182/blood-2019-123998

Published: 2019

Journal Articles

Patient Reported Financial Toxicity in Myeloproliferative Neoplasms

Thomas G. Knight, MD, Myra Robinson, MS, Jing Ai, MD PhD, Brittany K Ragon, MD, Rhonda Davis, RN, BSN, Cindy Shiflett, LPN, Erica Ruston, RN, BSN, Hailey Glover, RN, BSN, Jigar Trivedi, MSc, PharmD, Belinda R Avalos, MD, Jonathan M. Gerber, MD, James T Symanowski, PhD, Edward A Copelan, Michael R. Grunwald, MD

Blood (2019) 134 (Supplement_1): 2099.

https://doi.org/10.1182/blood-2019-128858

Published: 2019

Journal Articles

Alternative Splicing and Intronic Polyadenylation Post-Transcriptionally Regulate CSF3R Via a Cryptic Exon

Lawrence J Druhan, PhD, Amanda Lance, MS, Alicia Hamilton, Nury M Steuerwald, PhD, Elise Tjaden, Belinda R Avalos, MD

Blood (2019) 134 (Supplement_1): 2462.

https://doi.org/10.1182/blood-2019-129102

Published: 2019

Journal Articles

New Germline Syndrome Discovery: Heterozygous CSF3R Mutations May Predispose to Myeloid and Lymphoid Malignancies

Amy M Trottier, MDBSc,MSc, Ira L Kraft, MD, Lawrence J Druhan, PhD, Amanda Lance, MS, Belinda R Avalos, MD, Lucy A Godley, MD PhD

Blood (2019) 134 (Supplement_1): 2543.

https://doi.org/10.1182/blood-2019-129492

Published: 2019

Journal Articles

Peripheral Immune Profile and Minimal Residual Disease (MRD) Burden Following Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM)

David Foureau, PhD, Qing Zhang, PhD, Tammy D Cogdill, NP, Adina S Wynn, Nury M. Steuerwald, PhD, Lawrence J. Druhan, PhD, Fei Guo, Katherine Rigby, Kyle L Madden, BS, James T Symanowski, PhD, Belinda R. Avalos, MD, Edward A. Copelan, MD FACP, Saad Z Usmani, MD FACP, Manisha Bhutani, MD

Blood (2016) 128 (22): 378.

https://doi.org/10.1182/blood.V128.22.378.378

Published: 2016

Journal Articles

CYP2C19 Genotype-Guided Dosing and Voriconazole Concentrations in Hematopoietic Stem Cell Transplant Patients (HSCT) Receiving Antifungal Prophylaxis

Jai N Patel, PharmD, Myra M Robinson, Issam Hamadeh, PharmD, Zainab Shahid, MD, James T Symanowski, PhD, Dragos Plesca, PharmD, PhD, Margaret Croom, PharmD, Jigar Trivedi, MSc, PharmD, Nury M. Steuerwald, PhD, Belinda R. Avalos, MD, Edward A. Copelan, MD FACP

Blood (2016) 128 (22): 3416.

https://doi.org/10.1182/blood.V128.22.3416.3416

Published: 2016

Journal Articles

Fluorescence in Situ Hybridization (FISH) abnormalities and Baseline Clinical Features at Diagnosis in African American Multiple Myeloma Patients

Megan H Jagosky, MD, Kyle L Madden, BS, Blake B Goodbar, MD, Virginia Thurston, PhD, Manisha Bhutani, MD, Preeya Patel, BS, Myra M Robinson, Rupali Bose, Jill Eddy, Candice G Roth, RN, MSN, Lynn S Sanders, MSN, RN, OCN, James T Symanowski, PhD, Tammy D Cogdill, NP, Belinda R. Avalos, MD, Edward A. Copelan, MD FACP, Saad Z Usmani, MD FACP

Blood (2016) 128 (22): 2351.

https://doi.org/10.1182/blood.V128.22.2351.2351

Published: 2016

Journal Articles

Outcomes in Transplant Eligible Multiple Myeloma African American Patients Appear Similar to Caucasian Patients

Megan H Jagosky, MD, Kyle L Madden, BS, Myra M Robinson, Blake B Goodbar, MD, Manisha Bhutani, MD, Preeya Patel, BS, Rupali Bose, Jill Eddy, Sarah LeStrange, Candice G Roth, RN, MSN, Lynn S Sanders, MSN, RN, OCN, James T Symanowski, PhD, Tammy D Cogdill, NP, Dragos Plesca, PharmD, PhD, Belinda R. Avalos, MD, Edward A. Copelan, MD FACP, Saad Z Usmani, MD FACP

Blood (2016) 128 (22): 2352.

https://doi.org/10.1182/blood.V128.22.2352.2352

Published: 2016

Journal Articles

Establishment of Subspecialized Care in Hematologic Malignancies and a Hematopoietic Cell Transplantation Program

Edward A. Copelan, MD FACP, Jonathan M. Gerber, MD, Saad Z Usmani, MD FACP, Michael R. Grunwald, MD, Nilanjan Ghosh, MD PhD, Omotayo O. Fasan, MBBS, MRCP, Manisha Bhutani, MD, James T Symanowski, PhD, Derek Raghavan, MD PhD FACP, FRACP, FASCO, Belinda R. Avalos, MD

Blood (2016) 128 (22): 3580.

https://doi.org/10.1182/blood.V128.22.3580.3580

Published: 2016

Journal Articles

A Novel Approach to Identify a Putative Leukemia Stem Cell Population in Acute Lymphocytic Leukemia (ALL) and Distinguish Philadelphia Chromosome-Positive ALL from Lymphoid Blast Crisis Chronic Myeloid Leukemia

Jonathan M. Gerber, MD, Lawrence J. Druhan, PhD, David Foureau, PhD, Elizabeth Jandrisevits, Amanda Lance, BS, Andrea E. Price, BS, Virginia Thurston, PhD, Jing Ai, MD PhD, Michael R. Grunwald, MD, Edward H. Lipford, MD, Belinda R. Avalos, MD

Blood (2016) 128 (22): 2912.

https://doi.org/10.1182/blood.V128.22.2912.2912

Published: 2016

Journal Articles

Optimizing Progenitor Cell Mobilization in Patients with Myeloma: Effect of a Pre-Emptive Day 4 Plerixafor-Based Mobilization Algorithm

Omotayo O. Fasan, MBBS, MRCP, Saad Z Usmani, MD FACP, Danyu Sun, MD PhD, Ryan Jacobs, MD, Carlos Lee, BSc, Jigar Trivedi, MSc, PharmD, Eric Chow, PharmD, Dragos Plesca, PharmD, PhD, Manisha Bhutani, MD, Belinda R. Avalos, MD, Edward A. Copelan, MD FACP

Blood (2016) 128 (22): 2184.

https://doi.org/10.1182/blood.V128.22.2184.2184

Published: 2016

Journal Articles

NF-κb / STAT3 Signaling Pathway Collaboration in Diffuse Large B-Cell Lymphoma (DLBCL) Cell-of-Origin (COO) Subtypes: Resolution of Myeloid Subversion By Standard Induction Chemotherapy

David Foureau, PhD, Qing Zhang, PhD, Lawrence J. Druhan, PhD, Nury M. Steuerwald, PhD, Fei Guo, Elizabeth Jandrisevits, Belinda R. Avalos, MD, Danyu Sun, MD PhD, Ryan Jacobs, MD, Nilanjan Ghosh, MD PhD

Blood (2016) 128 (22): 4133.

https://doi.org/10.1182/blood.V128.22.4133.4133

Published: 2016

Journal Articles

Impact of Lenalidomide Maintenance Therapy on Immune Polarization and Activation in Multiple Myeloma

Manisha Bhutani, MD, David Foureau, PhD, Tammy Cogdill, NP, Kyle Madden, BS, Qing Zhang, PhD, Sarah A Baxter, PhD, Lawrence J Druhan, PhD, Nilanjan Ghosh, MD PhD, Belinda R Avalos, MD, Edward A. Copelan, MD, Saad Z Usmani, MD FACP

Blood (2015) 126 (23): 2966.

https://doi.org/10.1182/blood.V126.23.2966.2966

Published: 2015

Journal Articles

Identification and Validation of IMiD-14 Model Predictive of IMiD Resistance in Multiple Myeloma

Manisha Bhutani, MD, Qing Zhang, PhD, Sarah A Baxter, PhD, Lawrence J Druhan, PhD, Bart Barlogie, Pieter Sonneveld, MD PhD, Belinda R Avalos, MD, Edward A. Copelan, MD, Saad Z Usmani, MD FACP

Blood (2015) 126 (23): 4183.

https://doi.org/10.1182/blood.V126.23.4183.4183

Published: 2015

Journal Articles

Congenital Neutrophilia Arising from a T618I Germline Mutation in the CSF3R Gene

Daniel P McMahon, MD, Amanda Lance, BS, Andrea E. Price, BS, Jonathan M. Gerber, MD, Sarah A Baxter, PhD, Lawrence J Druhan, PhD, Nury M Steuerwald, PhD, Belinda R Avalos, MD

Blood (2015) 126 (23): 1623.

https://doi.org/10.1182/blood.V126.23.1623.1623

Published: 2015

Journal Articles

Distribution of Cytogenetic Abnormalities in African American Multiple Myeloma Patients May be Unique for Different Geographic Regions

Manisha Bhutani, MD, Preeya Patel, BS, Myra M Robinson, Rupali Bose, Kyle Madden, BS, Jill Eddy, Candice G Roth, RN, MSN, James Symanowski, Tammy Cogdill, NP, Jordan Robinson, PA-C, Belinda R Avalos, MD, Edward A. Copelan, MD, Saad Z Usmani, MD FACP

Blood (2015) 126 (23): 5337.

https://doi.org/10.1182/blood.V126.23.5337.5337

Published: 2015

NARROW

Characteristics Affecting Durability and Tolerability of Imatinib in Patients Switched from Brand to Generic and Newly Diagnosed Patients Initially Prescribed Generic Imatinib for Chronic Myeloid Leukemia

Impact of Letermovir Prophylaxis on Voriconazole Exposure in Allogeneic Hematopoietic Cell Transplant Recipients

Complex CSF3R Protein Isoform Interactions Dictate Cytokine Responsiveness

Specialty Pharmacy and Physician Partnership Optimizes Clinical Pathway Adherence in Myelofibrosis (MF): Initial Analysis of a Quality Improvement Initiative

Minorities Do Not Have Worse Outcomes for Diffuse Large B Cell Lymphoma (DLBCL) If Optimally Managed

Patient Reported Financial Toxicity in Myeloproliferative Neoplasms

Alternative Splicing and Intronic Polyadenylation Post-Transcriptionally Regulate CSF3R Via a Cryptic Exon

New Germline Syndrome Discovery: Heterozygous CSF3R Mutations May Predispose to Myeloid and Lymphoid Malignancies

Peripheral Immune Profile and Minimal Residual Disease (MRD) Burden Following Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM)

CYP2C19 Genotype-Guided Dosing and Voriconazole Concentrations in Hematopoietic Stem Cell Transplant Patients (HSCT) Receiving Antifungal Prophylaxis

Fluorescence in Situ Hybridization (FISH) abnormalities and Baseline Clinical Features at Diagnosis in African American Multiple Myeloma Patients

Outcomes in Transplant Eligible Multiple Myeloma African American Patients Appear Similar to Caucasian Patients

Establishment of Subspecialized Care in Hematologic Malignancies and a Hematopoietic Cell Transplantation Program

A Novel Approach to Identify a Putative Leukemia Stem Cell Population in Acute Lymphocytic Leukemia (ALL) and Distinguish Philadelphia Chromosome-Positive ALL from Lymphoid Blast Crisis Chronic Myeloid Leukemia

Optimizing Progenitor Cell Mobilization in Patients with Myeloma: Effect of a Pre-Emptive Day 4 Plerixafor-Based Mobilization Algorithm

NF-κb / STAT3 Signaling Pathway Collaboration in Diffuse Large B-Cell Lymphoma (DLBCL) Cell-of-Origin (COO) Subtypes: Resolution of Myeloid Subversion By Standard Induction Chemotherapy

Impact of Lenalidomide Maintenance Therapy on Immune Polarization and Activation in Multiple Myeloma

Identification and Validation of IMiD-14 Model Predictive of IMiD Resistance in Multiple Myeloma

Congenital Neutrophilia Arising from a T618I Germline Mutation in the CSF3R Gene

Distribution of Cytogenetic Abnormalities in African American Multiple Myeloma Patients May be Unique for Different Geographic Regions

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only